Canaccord Adams
http://www.canaccordadams.com/default.htmCanaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, their 225 professionals seek out emerging opportunities in their key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate and Gaming, Consumer and Industrial Growth. Located in nine offices internationally, their experienced team generates focused, actionable ideas that identify opportunity and facilitate growth.
View Older Stories View More Recent Stories
-
Canaccord Adams Reiterates a 'Buy' on Nalco Holding (NLC); Investor Day Update -- Part 1
-
Canaccord Adams Reiterates a 'Buy' on Analog Devices (ADI); Non-Consumer Verticals Drive Upside
-
Canaccord Adams Reiterates a 'Buy' on American Oil & Gas (AEZ); Announces In-Line Quarter
-
Magellan Petroleum (MPET) Announces Additional $15.6M Investment in Young Energy Prize
-
Canaccord Adams Maintains a 'Buy' on RINO International (RINO); Lower Margin and Reduced Growth Forecast for 2011
-
Canaccord Adams Maintains a 'Buy' on Avanir Pharmaceuticals (AVNR); Zenvia PDUFA Date
-
Canaccord Adams Reiterates a 'Buy' on EnerNOC (ENOC); PJM Shows Nice Volume and Price
-
Canaccord Adams Maintains a 'Hold' on Darling International (DAR);Core Intact, Waiting On Biofuel Business in Q4
-
Canaccord Adams Maintains a 'Hold' on Cardiome Pharma (CRME); AVRO Results In Line, Focus Now on EMEA Decision
-
Canaccord Adams Reiterates a 'Buy' on Magnum Hunter Resources (MHR); Raises PT on Multiple Catalysts
-
Citi Cuts Estimates & PT on Monsanto (MON) After Recent Channel Checks; Favorite Pick Still Agrium (AGU)
-
Canaccord Adams Initiates Coverage on The Inventure Group (SNAK) with a Buy; Berry Good Growth opportunities
-
Canaccord Adams Reiterates a 'Buy' on NxStage Medical (NXTM); Adds to Best Ideas List
-
Canaccord Adams Reiterates a 'Buy' on NVIDIA (NVDA); Top-line Guidance Appears Conservative
-
Canaccord Adams Initiates Coverage on Lance Inc. (LNCE) with a Hold; Transformation in Process with N-T Challenges
-
Canaccord Adams Reiterates a 'Buy' on BPZ Energy (BPZ); Well Abandoned at Albacora
-
Canaccord Adams Reiterates a 'Buy' on EXCO Resources (XCO); Positive on Joint Venture
-
Canaccord Adams Reiterates a 'Buy' on American Oil & Gas (AEZ); Solid Q1/10 Results Include Promising New Well Results
-
Canaccord Adams Reiterates a 'Buy'on Northgate Minerals (NXG); Q1/10 Miss on Higher Cash Costs; Hope for Kemess North;
-
AVANIR (AVNR) Closes 11.5M Share Offering for Net Proceeds of $26.6M
-
Canaccord Adams Reiterates a 'Strong Buy' on Radiant Systems (RADS); Return Of The Channel & Continued SaaS Traction
-
Canaccord Adams Downgrades Fuel Systems Solutions (FSYS) to Hold; Looking for Better Visibility
-
Canaccord Adams Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); More Positive Fidaxo Data, NDA Filing Expected in H2/10
-
Canaccord Adams Reiterates a 'Buy' on Cadence Pharmaceuticals (CADX); Progress Made with Resubmission of Ofirmev NDA
-
Canaccord Adams Reiterates a 'Buy' on Luminex (LMNX); Raises PT & Estimates
-
Canaccord Adams Reiterates a 'Buy' on Insulet Corp. (PODD); Raises PT After Q1 Report
-
Canaccord Adams Maintains a 'Buy' on Integrated Device Technology (IDTI); Adding to List of Best Ideas Following Sharp Sell-off
-
Canaccord Adams Reiterates a 'Buy' on Penn Virginia Corporation (PVA); Becoming a Pure Play E&P
-
Canaccord Adams Reiterates a 'Buy' on ATP Oil & Gas (ATPG); Telemark Hub - Up and Running
-
Canaccord Adams Reiterates a 'Buy' on Northern Oil and Gas (NOG); Beginning the Year with Impactful Acreage Acquisitions
-
Canaccord Adams Upgrades Superior Well Services (SWSI) to Buy; Higher Top-Line Growth on Better Activity Levels
-
Canaccord Adams Maintains a 'Buy' on New Gold Inc. (NGD); Recognizing Further Upside Potential from El Morro
-
Canaccord Adams Upgrades Thompson Creek Metals (TC) to Buy; Good Q1 Financials on Price and Cost
-
Canaccord Adams Reiterates a 'Buy' on EnerNOC (ENOC); A Clean MW Machine
-
Canaccord Adams Reiterates a 'Buy' on Medifast (MED); Abundant Momentum
-
Canaccord Adams Maintains a 'Buy' on Hain Celestial Group (HAIN); Destocking Offsets Return to Consumption Growth
-
Canaccord Adams Maintains a 'Buy' on Medicis Pharmaceutical (MRX); Acne Drives Q1/10 Outperformance
-
Canaccord Adams Reiterates a 'Buy' on ON Semiconductor (ONNN); More Earnings Upside Likely in 2010
-
Canaccord Adams Reiterates a 'Buy' on Microchip Technology (MCHP); Book-to-bill Remains Substantially Above 1:1
-
Canaccord Adams Reiterates a 'Buy' on 3D Systems (TDSC); Foresee Revenue Growth Through Remainder of 2010
-
Canaccord Adams Reiterates a 'Buy' on Rex Energy (REXX); Q1 Results In-Line and Drill Program on Schedule
-
Canaccord Adams Reiterates a 'Buy' on EXCO Resources (XCO); Lean and Well Hedged
-
Analyst Round-Up InterMune (ITMN): 6 Downgrades Following FDA's Request for More Trials
-
Notable Analyst Rating Changes 05/05: S, CAb, ERTS, AMMD Upgraded; ITMN, MRK, NWSA, MYGN Downgraded
-
Intermune (ITMN) option prices expensive into FDA for request for additional data
-
Canaccord Adams Downgraded InterMune (ITMN) to Hold, $10 Tgt

